Several studies presented at the 2025 meeting of the American College of Cardiology strengthen the case that purified EPA from fish oil (Icosapent Ethyl) lowers risk of heart attacks and strokes.
This is true even in patients who are already at an appropriately low LDL target, especially if they still have elevated triglycerides.
radcliffecardiology.comAcc highlights updates icosapent ethyl and cardiometabolic riskradcliffecardiology.com


